aTYR PHARMA INC (ATYR) Financial Statements (2026 and earlier)

Company Profile

Business Address 10240 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments78,68772,12598,16666,146107,91131,689
Cash and cash equivalent10,74311,05522,5449,9812,33616,952
Short-term investments67,94461,07075,62256,165105,57514,737
Receivables8731,7362,43611,7754352,039
Prepaid expense6778,0932,3902,9505,2231,803
Total current assets:80,23781,954102,99280,871113,56935,531
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization5961,1921,7881,248  
Operating lease, right-of-use asset5,5245,8176,7277,2501,2672,083
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization4,2634,8505,5313,059543899
Restricted cash and investments2,2352,9513,4843,165  
Other noncurrent assets14866131193158213
Total noncurrent assets:12,76614,87617,66114,9151,9683,195
TOTAL ASSETS:93,00396,830120,65395,786115,53738,726
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,68213,71515,08812,9685,0335,003
Accounts payable3,8914,3233,5293,1061,0311,431
Accrued liabilities9,7919,39211,5599,8624,0023,572
Debt630541497264  
Other undisclosed current liabilities836711831630980861
Total current liabilities:15,14814,96716,41613,8626,0135,864
Noncurrent Liabilities
Long-term debt and lease obligation2598871,4281,0073981,378
Finance lease, liability2598871,4281,007  
Liabilities, other than long-term debt10,30811,14412,3399,633  
Operating lease, liability10,30811,14412,3399,6333981,378
Other undisclosed noncurrent liabilities     (398)(1,378)
Total noncurrent liabilities:10,56712,03113,76710,6403981,378
Total liabilities:25,71526,99830,18324,5026,4117,242
Equity
Equity, attributable to parent67,48070,01990,65871,464109,30131,650
Common stock988463292811
Additional paid in capital673,554602,021558,692489,502481,832370,210
Accumulated other comprehensive loss(8)(40)(74)(433)(263)(43)
Accumulated deficit(606,164)(532,046)(468,023)(417,634)(372,296)(338,528)
Equity, attributable to noncontrolling interest(192)(187)(188)(180)(175)(166)
Total equity:67,28869,83290,47071,284109,12631,484
TOTAL LIABILITIES AND EQUITY:93,00396,830120,65395,786115,53738,726

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues19023535310,386 10,455
Gross profit:19023535310,386 10,455
Operating expenses(77,817)(68,149)(55,272)(56,790)(34,015)(26,366)
Operating loss:(77,627)(67,914)(54,919)(46,404)(34,015)(15,911)
Nonoperating income (expense)3,5043,8924,5221,061238(319)
Loss from continuing operations before equity method investments, income taxes:(74,123)(64,022)(50,397)(45,343)(33,777)(16,230)
Other undisclosed income from continuing operations before income taxes   233 
Loss from continuing operations:(74,123)(64,022)(50,395)(45,340)(33,774)(16,230)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(33,774)(16,230)
Other undisclosed net loss   (2)(3)(3) 
Net loss:(74,123)(64,022)(50,397)(45,343)(33,777)(16,230)
Net income (loss) attributable to noncontrolling interest5(1)8596
Net loss available to common stockholders, diluted:(74,118)(64,023)(50,389)(45,338)(33,768)(16,224)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(74,123)(64,022)(50,397)(45,343)(33,777)(16,230)
Other undisclosed comprehensive income (loss)3234359(170)(220)(3)
Comprehensive loss:(74,091)(63,988)(50,038)(45,513)(33,997)(16,233)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest5(1)8596
Comprehensive loss, net of tax, attributable to parent:(74,086)(63,989)(50,030)(45,508)(33,988)(16,227)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: